A citation-based method for searching scientific literature

Massimo Santoro, Francesca Carlomagno. Cold Spring Harb Perspect Biol 2013
Times Cited: 67



Anne-France Le Rolle, Samuel J Klempner, Christopher R Garrett, Tara Seery, Eric M Sanford, Sohail Balasubramanian, Jeffrey S Ross, Philip J Stephens, Vincent A Miller, Siraj M Ali, Vi K Chiu. Oncotarget 2015
Times Cited: 71




List of shared articles



Times cited


Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development.
Debasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, Baku Acharya, Noemi Garcia Garcia, Erica Lane Smith, Brendan Frett. J Med Chem 2021
1

The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer.
Valentina De Falco, Francesca Carlomagno, Hong-Yu Li, Massimo Santoro. Best Pract Res Clin Endocrinol Metab 2017
21

OLFM4-RET fusion is an oncogenic driver in small intestine adenocarcinoma.
Wenli Liu, Hongzhen Li, Wulin Aerbajinai, Istvan Botos, Griffin P Rodgers. Oncogene 2022
3

State-of-the-Art Strategies for Targeting RET-Dependent Cancers.
Vivek Subbiah, Dong Yang, Vamsidhar Velcheti, Alexander Drilon, Funda Meric-Bernstam. J Clin Oncol 2020
80

ANKRD26-RET - A novel gene fusion involving RET in papillary thyroid carcinoma.
Julia Isabelle Staubitz, Thomas Johannes Musholt, Arno Schad, Erik Springer, Hauke Lang, Krishnaraj Rajalingam, Wilfried Roth, Nils Hartmann. Cancer Genet 2019
7

BCR: a promiscuous fusion partner in hematopoietic disorders.
Malalage N Peiris, Fangda Li, Daniel J Donoghue. Oncotarget 2019
9